Golgi retention and oncogenic KIT signaling via PLCγ2-PKD2-PI4KIIIβ activation in GIST cells
Y. Obata, K. Kurokawa, T. Tojima, M. Natsume, I. Shiina, T. Takahashi, R. Abe, A. Nakano, T. Nishida
Abstract
Most gastrointestinal stromal tumors (GISTs) develop due to gain-of-function mutations in the tyrosine kinase, KIT. We recently showed that mutant KIT mislocalizes to the Golgi area and initiates uncontrolled signaling. However, the molecular mechanisms underlying its Golgi retention remain unknown. Here, we show that protein kinase D2 (PKD2) is activated by the mutant, which causes KITs Golgi retention. In PKD2-inhibited cells, KIT migrates from the Golgi region to lysosomes and subsequently undergoes degradation. Importantly, delocalized KIT is unable to trigger downstream activation. In the Golgi area, KIT activates the PKD2-phosphatidylinositol 4-kinaseIII{beta} (PKD2-PI4KIII{beta}) pathway through phospholipase {gamma}2 (PLC{gamma}2) to generate a PI4P-rich membrane domain, where the AP1-GGA1 complex is aberrantly recruited. Disruption of any factors in this cascade results in KIT release from the Golgi region, indicating that these PKD2-related pathways are responsible for the Golgi retention of KIT. Our findings unveil the molecular mechanisms underlying KIT mislocalization and provide evidence for a new strategy for inhibition of oncogenic signaling.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent
Yuuki Obata, Miyuki Natsume, … Toshirou Nishida·Scientific ReportsPeer-reviewed·Aug 6, 2025
- Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
M. Kozinova, S. Joshi, … L. Rink·bioRxiv·Apr 13, 2021
- Enhanced PI3K/Akt Signaling in Response to p85α Loss is Regulated by Endosomal PI3Kα and PI3P
Narendra Thapa, Mo Chen, … Richard Anderson·Cell ReportsPeer-reviewed·Apr 16, 2024
- Identification of Wee1 as Target in Combination with Avapritinib for the Treatment of Gastrointestinal Stromal Tumors
S. Ye, D. Sharipova, … L. Rink·bioRxiv·Jun 7, 2020
- Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi
N. Kalogriopoulos, I. Lopez-Sanchez, … P. Ghosh·bioRxiv·Aug 9, 2020
- Atypical PI3Ks coordinate chemotaxis, signaling dynamics, and multicellular development in Dictyostelium
Laith Bahlouli, Erik J. Zhang, … Marc Edwards·Journal of Cell SciencePeer-reviewed·Aug 27, 2026